Back to NGNE
CITADEL ADVISORS LLC NGNE Position History
Neurogene Inc. • Healthcare
Quarters held
20
Latest value
$314K
Q3 2026
Peak value
$8.1M
First seen
Q4 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2024 | $713K |
| Q4 2024 | $880K |
| Q1 2025 | $475K |
| Q1 2025 | $117K |
| Q1 2025 | $192K |
| Q4 2025 | $6.1M |
| Q4 2025 | $1.4M |
| Q1 2026 | $4.7M |
| Q1 2026 | $304K |
| Q1 2026 | $3.1M |
| Q1 2026 | $224K |
| Q2 2026 | $4.7M |
| Q2 2026 | $840K |
| Q2 2026 | $8.1M |
| Q2 2026 | $4.7M |
| Q2 2026 | $840K |
| Q2 2026 | $8.1M |
| Q3 2026 | $1.1M |
| Q3 2026 | $2.6M |
| Q3 2026 | $314K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $314K | 11.3K | — | — |
| Q3 2026 | $2.6M | 92.9K | — | — |
| Q3 2026 | $1.1M | 40.7K | — | — |
| Q2 2026 | $8.1M | 258.0K | — | — |
| Q2 2026 | $840K | 26.7K | — | — |
| Q2 2026 | $4.7M | 150.9K | — | — |
| Q2 2026 | $8.1M | 258.0K | — | — |
| Q2 2026 | $840K | 26.7K | — | — |
| Q2 2026 | $4.7M | 150.9K | — | — |
| Q1 2026 | $224K | 11.1K | — | — |
| Q1 2026 | $3.1M | 152.8K | — | — |
| Q1 2026 | $304K | 15.1K | — | — |
| Q1 2026 | $4.7M | 234.2K | — | — |
| Q4 2025 | $1.4M | 66.9K | — | — |
| Q4 2025 | $6.1M | 297.3K | — | — |
| Q1 2025 | $192K | 16.4K | — | — |
| Q1 2025 | $117K | 10.0K | — | — |
| Q1 2025 | $475K | 40.6K | — | — |
| Q4 2024 | $880K | 38.5K | — | — |
| Q4 2024 | $713K | 31.2K | — | — |
Other funds holding NGNE
$51.9M
$51.7M
$48.6M
$44.4M
$44.1M
$43.5M
$42.8M